<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02894671</url>
  </required_header>
  <id_info>
    <org_study_id>83/14</org_study_id>
    <nct_id>NCT02894671</nct_id>
  </id_info>
  <brief_title>Ischemia Modified Albumin (IMA) Expression in the Male and Female Population</brief_title>
  <acronym>IMAandGENDER</acronym>
  <official_title>Ischemia Modified Albumin (IMA) Expression in the Male and Female Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istituto Ortopedico Rizzoli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istituto Ortopedico Rizzoli</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study has as general objective to analyze in the adult population, (male and female) the
      presence of a very common protein, in its normal form and modified, isolated from the blood
      of patients and called albumin. The opportunity to observe the distribution of this protein
      in the population, provides the basis to be able to perform this type of assay also in the
      population of patients with pathologies, in the near future, with the aim of increasing
      knowledge on the subjective tolerability to orthopedic implants.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      100 patients, waiting for elective surgical intervention (such as hip replacement or primary
      knee ligament reconstruction, arthroscopy), distributed evenly by gender and age (50 men, 50
      women including 25 postmenopausal and 25 in bearing age) and afferent to the Department of
      Surgery Prosthetic hip and knee of our Institute, will be enrolled. At execution time of
      blood sampling routine, a further specimen of whole blood (7 ml) will be added which will be
      sent to the Medical technology laboratory for IMA dosage. In addition, total albumin,
      ferritin, transferrin and serum iron will be analyzed from clinical pathological laboratory.
      The investigators will be able to analyze the IMA and normalized IMA distributions with
      respect to gender factor and correlation with the three listed blood tests (ferritin,
      transferrin and serum iron).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Actual">February 2016</completion_date>
  <primary_completion_date type="Actual">February 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>IMA dosage</measure>
    <time_frame>one year</time_frame>
    <description>Dosage of IMA (mg/ml), with ELISA assay for each patient</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>iron, transferrin dosages</measure>
    <time_frame>one year</time_frame>
    <description>Dosage of iron and transferrin (mg/ml) values in patients blood</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ferritin dosages</measure>
    <time_frame>one year</time_frame>
    <description>Dosage of ferritin (ng/ml) values in patients blood</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>Group Identification</condition>
  <arm_group>
    <arm_group_label>male under 45y</arm_group_label>
    <description>blood exams performed on males under 45years (in a range of 20-90 years) not wearing articular devices, without fractures, and without these diseases: oncologic, hemochromatosis, hepatic, thalassaemia, diabetes, anemia (Hb&lt;9)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>male over 45y</arm_group_label>
    <description>blood exams performed on males over 45years (in a range of 20-90 years) not wearing articular devices, without fractures, and without these diseases: oncologic, hemochromatosis, hepatic, thalassaemia, diabetes, anemia (Hb&lt;9)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>fertile female</arm_group_label>
    <description>blood exams performed on fertile females (in a range of 20-90 years) not wearing articular devices, no pregnant, without fractures, and without these diseases: oncologic, hemochromatosis, hepatic, thalassaemia, diabetes, anemia (Hb&lt;9)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>infertile female</arm_group_label>
    <description>blood exams performed on infertile females (in a range of 20-90 years) not wearing articular devices, no pregnant, without fractures, and without these diseases: oncologic, hemochromatosis, hepatic, thalassaemia, diabetes, anemia (Hb&lt;9)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>blood exams</intervention_name>
    <description>in serum will be analyzed the level of IMA, iron, transferrin, ferritin, total albumin</description>
    <arm_group_label>male under 45y</arm_group_label>
    <arm_group_label>male over 45y</arm_group_label>
    <arm_group_label>fertile female</arm_group_label>
    <arm_group_label>infertile female</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum vials
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        25 males under 45y, 25 males over 45y, 25 fertile females and 25 infertile females
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        -  Inclusion Criteria:

          -  caucasic

          -  signed informative consensus

          -  Exclusion Criteria:

          -  patients wearing articular devices

          -  pregnant (for female)

          -  fractured patients

          -  patients with oncologic diseases, hemochromatosis, hepatic diseases, thalassaemia,
             diabetes, anemia (Hb&lt;9)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giovanni Bracci, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Istituto Ortopedico Rizzoli</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Istituto Ortopedico Rizzoli - Laboratorio Tecnologia Medica</name>
      <address>
        <city>Bologna</city>
        <zip>40136</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Govender R, De Greef J, Delport R, Becker PJ, Vermaak WJ. Biological variation of ischaemia-modified albumin in healthy subjects. Cardiovasc J Afr. 2008 May-Jun;19(3):141-4.</citation>
    <PMID>18568173</PMID>
  </reference>
  <reference>
    <citation>Catalani S, Leone R, Rizzetti MC, Padovani A, Apostoli P. The role of albumin in human toxicology of cobalt: contribution from a clinical case. ISRN Hematol. 2011;2011:690620. doi: 10.5402/2011/690620. Epub 2010 Oct 31.</citation>
    <PMID>22084701</PMID>
  </reference>
  <reference>
    <citation>Bar-Or D, Rael LT, Lau EP, Rao NK, Thomas GW, Winkler JV, Yukl RL, Kingston RG, Curtis CG. An analog of the human albumin N-terminus (Asp-Ala-His-Lys) prevents formation of copper-induced reactive oxygen species. Biochem Biophys Res Commun. 2001 Jun 15;284(3):856-62.</citation>
    <PMID>11396981</PMID>
  </reference>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 12, 2016</study_first_submitted>
  <study_first_submitted_qc>September 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2016</study_first_posted>
  <last_update_submitted>September 5, 2016</last_update_submitted>
  <last_update_submitted_qc>September 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 9, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istituto Ortopedico Rizzoli</investigator_affiliation>
    <investigator_full_name>Giovanni Bracci</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

